bezafibrate has been researched along with gw 1929 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, PJ; Henke, BR; Sternbach, DD; Willson, TM | 1 |
| Amita, M; Hara, S; Igarashi, H; Kurachi, H; Takahashi, T; Tsutsumi, S | 1 |
1 review(s) available for bezafibrate and gw 1929
| Article | Year |
|---|---|
The PPARs: from orphan receptors to drug discovery.
Topics: Animals; Diabetes Mellitus; Drug Design; Humans; Hyperlipidemias; Hypertension; Inflammation; Ligands; Models, Molecular; Neoplasms; Nuclear Proteins; Obesity; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 2000 |
1 other study(ies) available for bezafibrate and gw 1929
| Article | Year |
|---|---|
Bezafibrate restores the inhibition of FSH-induced follicular development and steroidogenesis by tumor necrosis factor-alpha through peroxisome proliferator-activated receptor-gamma pathway in an in vitro mouse preantral follicle culture.
Topics: Anilides; Animals; Benzophenones; Bezafibrate; Cells, Cultured; Female; Follicle Stimulating Hormone; Hypolipidemic Agents; In Vitro Techniques; Mice; Mice, Inbred ICR; Models, Animal; Ovarian Follicle; PPAR gamma; Signal Transduction; Steroids; Tumor Necrosis Factor-alpha; Tyrosine | 2011 |